(Q51181259)

31 March 2018

title

Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. (English)

1 reference

31 March 2018

main subject

meningococcal disease

1 reference

1

1 reference

31 March 2018

Ray Borrow

10

object named as

Ray Borrow

1 reference

31 March 2018

Jessica S Flood

2

1 reference

31 March 2018

Mary E Ramsay

3

1 reference

31 March 2018

Helen Campbell

4

1 reference

31 March 2018

Stephen J Gray

5

1 reference

31 March 2018

Edward B Kaczmarski

6

1 reference

31 March 2018

Richard H Mallard

7

1 reference

31 March 2018

Malcolm Guiver

8

1 reference

31 March 2018

Lynne S Newbold

9

1 reference

31 March 2018

language of work or name

English

0 references

publication date

17 March 2012

1 reference

31 March 2018

published in

Vaccine

1 reference

31 March 2018

volume

30

1 reference

31 March 2018

issue

24

1 reference

31 March 2018

page(s)

3710-3716

1 reference

31 March 2018

Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Emergency management of meningococcal disease: eight years on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Advances in the development of vaccines against Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Meningococcal glycoconjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Epidemiology and meningococcal serogroup distribution in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Meningococcal disease: the advances and challenges of meningococcal disease prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Meningococcal conjugate vaccines: new opportunities and new challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

The transposon-like Correia elements encode numerous strong promoters and provide a potential new mechanism for phase variation in the meningococcus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Capsule switching of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Meningococcal carriage by age: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Meningococcal carriage and disease--population biology and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Serogroup Y meningococcal disease, Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Emergence and disappearance of W135 meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.011

10.1016/J.VACCINE.2012.03.011

7 January 2021

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018